Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids.

Deykin A, Lazarus SC, Fahy JV, Wechsler ME, Boushey HA, Chinchilli VM, Craig TJ, Dimango E, Kraft M, Leone F, Lemanske RF, Martin RJ, Pesola GR, Peters SP, Sorkness CA, Szefler SJ, Israel E; Asthma Clinical Research Network, National Heart, Lung, and Blood Institute/NIH.

J Allergy Clin Immunol. 2005 Apr;115(4):720-7.

PMID:
15805990
2.

Safety and application of induced sputum analysis in childhood asthma.

Covar RA, Spahn JD, Martin RJ, Silkoff PE, Sundstrom DA, Murphy J, Szefler SJ.

J Allergy Clin Immunol. 2004 Sep;114(3):575-82.

PMID:
15356559
3.

Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.

Currie GP, Syme-Grant NJ, McFarlane LC, Carey FA, Lipworth BJ.

Allergy. 2003 Jul;58(7):602-7.

4.

Predictors for failed dose reduction of inhaled corticosteroids in childhood asthma.

Li AM, Tsang TW, Lam HS, Sung RY, Chang AB.

Respirology. 2008 May;13(3):400-7. doi: 10.1111/j.1440-1843.2007.01222.x.

PMID:
18399863
5.

Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids.

Maneechotesuwan K, Supawita S, Kasetsinsombat K, Wongkajornsilp A, Barnes PJ.

J Allergy Clin Immunol. 2008 Jan;121(1):43-50. Epub 2007 Nov 26.

PMID:
18036645
6.

Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma.

Hothersall EJ, Chaudhuri R, McSharry C, Donnelly I, Lafferty J, McMahon AD, Weir CJ, Meiklejohn J, Sattar N, McInnes I, Wood S, Thomson NC.

Thorax. 2008 Dec;63(12):1070-5. doi: 10.1136/thx.2008.100198. Epub 2008 Aug 29.

PMID:
18757458
7.

A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation.

Berlyne GS, Parameswaran K, Kamada D, Efthimiadis A, Hargreave FE.

J Allergy Clin Immunol. 2000 Oct;106(4):638-44.

PMID:
11031333
8.

Assessment of inhaled BDP-dose dependency of exhaled nitric oxide and local and serum eosinophilic markers in steroids-naive nonatopic asthmatics.

Dal Negro R, Micheletto C, Tognella S, Turco P, Rossetti A, Cantini L.

Allergy. 2003 Oct;58(10):1018-22.

9.

Characteristics of asthma resistant to moderate dose inhaled corticosteroid treatment on bronchial hyperresponsiveness.

Fujimoto K, Yamaguchi S, Urushibata K, Hanaoka M, Koizumi T, Honda T, Kubo K.

Intern Med. 2006;45(14):843-9. Epub 2006 Aug 15.

10.

Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.

Paro-Heitor ML, Bussamra MH, Saraiva-Romanholo BM, Martins MA, Okay TS, Rodrigues JC.

Pediatr Pulmonol. 2008 Feb;43(2):134-41.

PMID:
18085692
11.

Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial.

Lapperre TS, Snoeck-Stroband JB, Gosman MM, Jansen DF, van Schadewijk A, Thiadens HA, Vonk JM, Boezen HM, Ten Hacken NH, Sont JK, Rabe KF, Kerstjens HA, Hiemstra PS, Timens W, Postma DS, Sterk PJ; Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease Study Group.

Ann Intern Med. 2009 Oct 20;151(8):517-27.

PMID:
19841453
12.

Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.

Pinto Pereira LM, Clement Y, Rouse J, Matthew J, Asgarali Z, Ramoutar D, Teelucksingh S.

Int J Clin Pharmacol Res. 2003;23(2-3):69-74.

PMID:
15025036
13.
14.

Analysis of induced sputum before and after withdrawal of treatment with inhaled corticosteroids in asthmatic patients.

Giannini D, Di Franco A, Cianchetti S, Bacci E, Dente FL, Vagaggini B, Paggiaro PL.

Clin Exp Allergy. 2000 Dec;30(12):1777-84.

PMID:
11122217
15.

Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.

Rowe BH, Wong E, Blitz S, Diner B, Mackey D, Ross S, Senthilselvan A.

Acad Emerg Med. 2007 Oct;14(10):833-40.

16.

Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.

Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR.

N Engl J Med. 2005 May 26;352(21):2163-73. Epub 2005 May 24.

17.

Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.

Delea TE, Hagiwara M, Stanford RH, Stempel DA.

Clin Ther. 2008 Mar;30(3):560-71. doi: 10.1016/j.clinthera.2008.03.011.

PMID:
18405796
18.

Effect of a 4-week treatment with theophylline on sputum eosinophilia and sputum eosinophil chemotactic activity in steroid-naive asthmatics.

Louis R, Bettiol J, Cataldo D, Sele J, Henquet M, Radermecker M.

Clin Exp Allergy. 2000 Aug;30(8):1151-60.

19.

Effects of the addition of Beta2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma.

Hozawa S, Haruta Y, Terada M, Yamakido M.

Allergol Int. 2009 Dec;58(4):509-18. doi: 10.2332/allergolint.08-OA-0060. Epub 2009 Aug 25.

20.

Supplemental Content

Support Center